logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10614920 B1

PDFFull Text
Date of Patent:
Apr. 07, 2020

Filed:

Feb. 22, 2017

System and method for computing survivorship risk associated with delaying therapy in breast cancer

Applicant:

International Business Machines Corporation, Armonk, NY (US);

Inventors:

Jonathan Lenchner, Nairobi, KE;

Charity Wayua, Nairobi, KE;

Assignee:

International Business Machines Corporation, Armonk, NY (US);

Attorneys:

Eyal Gilboa

Otterstedt, Wallace & Kammer, LLP

Primary Examiner:

Elaine Gort

Assistant Examiner:

Nicholas Akogyeram, II

Int. Cl.
CPC ...
G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01); G16H 10/40 (2018.01); G06F 19/00 (2018.01); G01N 33/48 (2006.01); G01N 33/50 (2006.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
G16H 50/20 (2018.01); G06F 19/324 (2013.01); G16H 10/40 (2018.01); G16H 50/30 (2018.01);
Abstract

An estimate is made of a time since a given presenting cancer would have first been detectable using a known diagnostic technique, and an estimate is also made of initial characteristics of the given presenting cancer at the time when it would have first been detectable using the known diagnostic technique. A first probability of the cancer being present in a first set of one or more clinically significant remote sites is determined based on the estimated initial characteristics. A second probability of the cancer being present in the first set of one or more clinically significant remote sites is determined based on actual current characteristics of the given presenting cancer. The first and second probabilities are used to estimate incremental risk of incurring presence of the cancer at the first set of one or more clinically significant remote sites by delaying therapy for a unit time.

Find Patent Forward Citations

Lenchner, Jonathan. (2020). System and method for computing survivorship risk associated with delaying therapy in breast cancer (U.S. Patent No. 10614920). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10614920

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…